Increase in plasma esterified F2-isoprostanes following intravenous iron infusion in patients on hemodialysis
- 1 October 2001
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 60 (4), 1525-1531
- https://doi.org/10.1046/j.1523-1755.2001.00976.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatmentNephrology Dialysis Transplantation, 2001
- Anemia management of adult hemodialysis patients in the U.S.: Results from the 1997 ESRD Core Indicators ProjectKidney International, 2000
- Oxidant stress in hemodialysis: Prevention and treatment strategiesKidney International, 2000
- Measurement of F2-isoprostanes as an index of oxidative stress in vivoFree Radical Biology & Medicine, 2000
- Atherosclerosis — An Inflammatory DiseaseThe New England Journal of Medicine, 1999
- Lack of association between ferritin level and measures of LDL oxidation: The ARIC StudyAtherosclerosis, 1998
- The isoprostanes: Unique bioactive products of lipid peroxidationProgress in Lipid Research, 1997
- Iron Overload Augments the Development of Atherosclerotic Lesions in RabbitsArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Body iron stores and presence of carotid atherosclerosis. Results from the Bruneck Study.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- IRON AND THE SEX DIFFERENCE IN HEART DISEASE RISKThe Lancet, 1981